Balchem Ownership
| BCPC Stock | USD 151.52 1.89 1.26% |
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 32.5 M | Current Value 32.6 M | Avarage Shares Outstanding 27.2 M | Quarterly Volatility 4.1 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Balchem |
Balchem Stock Ownership Analysis
About 91.0% of the company shares are held by institutions such as insurance companies. The book value of Balchem was currently reported as 33.27. The company last dividend was issued on the 26th of December 2023. Balchem had 3:2 split on the 21st of January 2010. Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York. Balchem Cp operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1382 people. For more info on Balchem please contact Theodore Harris at 845 326 5600 or go to https://www.balchem.com.Besides selling stocks to institutional investors, Balchem also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Balchem's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Balchem's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Balchem Quarterly Liabilities And Stockholders Equity |
|
Balchem Insider Trades History
Less than 1% of Balchem are currently held by insiders. Unlike Balchem's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Balchem's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Balchem's insider trades
Balchem Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Balchem is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Balchem backward and forwards among themselves. Balchem's institutional investor refers to the entity that pools money to purchase Balchem's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ameriprise Financial Inc | 2023-12-31 | 450.4 K | Schroder Investment Management Group | 2024-03-31 | 413.1 K | Jpmorgan Chase & Co | 2023-12-31 | 404.7 K | Northern Trust Corp | 2023-12-31 | 399.8 K | Norges Bank | 2023-12-31 | 351.1 K | Charles Schwab Investment Management Inc | 2024-03-31 | 341.5 K | Stephens Inv Mgmt Group Llc | 2024-03-31 | 326.7 K | Gw&k Investment Management, Llc | 2023-12-31 | 305.3 K | Bank Of New York Mellon Corp | 2023-12-31 | 289.5 K | Blackrock Inc | 2023-12-31 | 5 M | Vanguard Group Inc | 2024-03-31 | 3.9 M |
Balchem Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Balchem insiders, such as employees or executives, is commonly permitted as long as it does not rely on Balchem's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Balchem insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
William Backus over a month ago Disposition of tradable shares by William Backus of Balchem at 155.6849 subject to Rule 16b-3 | ||
Tignor Michael Brent over two months ago Disposition of 4200 shares by Tignor Michael Brent of Balchem at 85.4 subject to Rule 16b-3 | ||
Matthew Wineinger over two months ago Disposition of 1333 shares by Matthew Wineinger of Balchem at 156.8851 subject to Rule 16b-3 | ||
William Backus over three months ago Disposition of 4319 shares by William Backus of Balchem at 155.6573 subject to Rule 16b-3 | ||
William Backus over three months ago Disposition of 3700 shares by William Backus of Balchem at 74.57 subject to Rule 16b-3 | ||
Tignor Michael Brent over six months ago Acquisition by Tignor Michael Brent of 2300 shares of Balchem subject to Rule 16b-3 | ||
Wedral Elaine R over a year ago Sale by Wedral Elaine R of 1854 shares of Balchem |
Balchem Corporate Filings
F4 | 13th of May 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 3rd of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 26th of April 2024 Other Reports | ViewVerify | |
13A | 9th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Balchem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Balchem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Balchem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Balchem Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Balchem Stock analysis
When running Balchem's price analysis, check to measure Balchem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Balchem is operating at the current time. Most of Balchem's value examination focuses on studying past and present price action to predict the probability of Balchem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Balchem's price. Additionally, you may evaluate how the addition of Balchem to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Balchem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Balchem. If investors know Balchem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Balchem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.271 | Dividend Share 0.79 | Earnings Share 3.51 | Revenue Per Share 28.912 | Quarterly Revenue Growth 0.031 |
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Balchem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balchem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balchem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.